Cumberland: Fourth Quarter Financial Results Overview

Cumberland Pharmaceuticals Reports Fourth Quarter Financial Results

Cumberland Pharmaceuticals Inc., headquartered in Nashville, Tennessee, announced on Tuesday that it experienced a net loss of $1.4 million during the fourth quarter.

The company indicated that this equates to a loss of 9 cents per share. After accounting for non-recurring items, the adjusted loss was 1 cent per share.

During the same quarter, Cumberland Pharmaceuticals generated $13.7 million in revenue.

Looking at the full year, the company recorded a total loss of $2.8 million, or 19 cents per share, with annual revenue reaching $44.5 million.